• Rocket-Like Nanomedicine Restores PDAC Stromal Homeostasis

  2026-08-27

  A 2026 Materials Today Bio study developed an acid-responsive, sequential-release nanomedicine that combines halofuginone and IPR-803 with gemcitabine to remodel pancreatic tumor stroma before chemotherapy delivery. The approach produced marked tumor regression in a pancreatic ductal adenocarcinoma mouse model and illustrates how competitive uPAR inhibition can be integrated into stroma-directed drug delivery.

• Protease Inhibitor Cocktail for Metabolic Signaling

  2026-08-26

  Discover how a Protease Inhibitor Cocktail EDTA-Free can protect signaling proteins during metabolic disease research. This guide connects pre-analytical sample control with the AMPK–PGC1α findings of a recent dAGE mouse study.

• Dabigatran for Thromboembolic Disease: Evidence Review

  2026-08-26

  This 2015 review examines dabigatran as the first widely introduced non-vitamin K oral anticoagulant, integrating pharmacology, randomized trial evidence, safety data, and practical management considerations. Its main contribution is a clinically oriented framework showing how predictable exposure, fixed dosing, and reduced intracranial hemorrhage can simplify prevention and treatment of thromboembolic disease while making renal function and bleeding management central to patient selection.

• Amplex Red for Reliable Cell Redox Assays

  2026-08-25

  Learn how Amplex Red (SKU C4839) supports sensitive hydrogen peroxide and peroxidase measurements while avoiding common cell-assay artifacts. This scenario-driven guide covers assay design, compatibility controls, protocol parameters, interpretation, and practical product selection for biomedical laboratories.

• Bafilomycin C1: From Lysosomes to Translational Screens

  2026-08-25

  A mechanistic and strategic guide to using Bafilomycin C1 as a lysosomal perturbation tool, autophagy control, and translational benchmark for high-content and iPSC-based research.

• CDK4/6–BET Synergy in Pancreatic Cancer

  2026-08-24

  Gu et al. show that palbociclib and the BET inhibitor JQ1 cooperate to suppress pancreatic ductal adenocarcinoma while counteracting the pro-invasive phenotype associated with CDK4/6 inhibition. The study links this effect to GSK3β-mediated Wnt/β-catenin signaling and its crosstalk with TGF-β/Smad, providing a mechanistic rationale for combination treatment rather than CDK4/6 blockade alone.

• Biotin-HPDP for Reversible Thiol Labeling

  2026-08-24

  Biotin-HPDP enables selective cysteine labeling, reversible streptavidin enrichment, and cleavable workflows for redox, palmitoylation, and affinity-purification studies. This practical guide connects its disulfide chemistry to S-nitrosylation assays and emerging biochemical questions in PPT1-related neurodegeneration.

• Doxycycline hyclate: Reliable MMP Assays

  2026-08-23

  Learn how Doxycycline hyclate, SKU A4052, can improve experimental control in viability, proliferation, cytotoxicity, and matrix metalloproteinase studies. This scenario-based guide connects product handling data with BBB, neurotoxicity, antiviral, and antimalarial research considerations.

• Bay 11-7085: NF-κB Assay Workflows

  2026-08-22

  Bay 11-7085 is a practical chemical probe for separating NF-κB-driven inflammation from downstream proliferation and apoptosis phenotypes. This guide translates its use into reproducible cell-based workflows, disease-model interpretation, and troubleshooting strategies.

• Ac-YVAD-CMK Workflows for Liver Inflammation

  2026-08-22

  Use Ac-YVAD-CMK to separate caspase-1-dependent cytokine maturation from membrane-repair defects in Kupffer-cell and liver inflammation models. This practical framework combines dose-ranging, pyroptosis readouts, and TMEM16F-focused controls for more interpretable infection assays.

• CX-4945 (Silmitasertib) CK2 Workflow Guide

  2026-08-21

  CX-4945 (Silmitasertib) turns CK2 biology into a practical, multi-readout workflow spanning target engagement, signaling, apoptosis, and cell-cycle analysis. This guide also shows how the inhibitor can be used as a mechanistic probe in the CSNK2A1-linked neuroinflammation findings reported in ischemic stroke research.

• Porcupine Inhibition for Severe Sclerosteosis

  2026-08-20

  This Bone Research study evaluates LGK974-mediated porcupine inhibition as a pharmacological strategy for sclerosteosis, a severe high-bone-mass disorder caused by loss of functional sclerostin. Combined cell and mouse experiments show reduced osteoblast activity and skeletal overgrowth, while also revealing sex-dependent differences in pathway engagement that are important for future translation.

• Bsa I (RNase-free): Practical Workflow Guide

  2026-08-20

  Bsa I (RNase-free) provides site-specific DNA cleavage for gene cloning and other DNA manipulation workflows in which RNA contamination should be minimized. It is intended for controlled molecular biology research, not diagnostic, clinical, or medical use.

• TMRE mitochondrial membrane potential assay kit Guide

  2026-08-19

  Build a quantitative workflow for measuring mitochondrial membrane potential in apoptosis, necrosis, and metabolic-stress models. This guide shows how to use TMRE with CCCP controls, plate-reader or imaging workflows, and orthogonal validation to distinguish true mitochondrial depolarization from loading and cell-number artifacts.

• Annexin V-Cy5: Translating Apoptosis Signals

  2026-08-19

  A mechanistic and strategic guide to using phosphatidylserine exposure as a decision point in microglial lysosomal-stress research, with practical guidance for flow cytometry, fluorescence microscopy, and translational assay design.

8350 records 1/557 page Next 12345 下5页 Last page